Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Califia Bio
AddedFeb 16, 2024
UpdatedJun 18, 2026
Califia Bio

Califia Bio

Pre-Seed

San Diego-based Alifia Bio Inc. develops treatments for neurodegenerative diseases, inflammation, and organ failure.

HQ
San Diego, CA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Founded in San Diego, Califia Bio Inc. is dedicated to developing innovative treatments for neurodegenerative diseases, inflammation, and organ failure. The company collaborates with academic research groups to address unmet therapeutic needs, aiming to improve patient outcomes and quality of life through cutting-edge biomedical research and development.

Califia Bio has garnered attention for its partnerships with leading academic institutions and researchers in the field. Notable achievements include advancements in therapeutic approaches for complex diseases, contributing significantly to the medical community's understanding and treatment options. The company's impact is reflected in its commitment to addressing critical health challenges and improving global healthcare standards.

Califia Bio - Similar Companies

BioHealthonomics logo

BioHealthonomics

Santa Ana Bio logo

Santa Ana Bio

santaanabio.com

KeifeRx logo

KeifeRx

keiferx.com

Selonterra logo

Selonterra

selonterra.com

Therini Bio logo

Therini Bio

therinibio.com

WinSanTor logo

WinSanTor

winsantor.com

Denali Therapeutics logo

Denali Therapeutics

Halia Therapeutics logo

Halia Therapeutics

Regenemed logo

Regenemed

regenemed.com

Epirium Bio logo

Epirium Bio

epirium.com

Enterin logo

Enterin

enterininc.com

Petri Bio logo

Petri Bio

petribio.com

Regennova logo

Regennova

regennova.com

Appia Bio logo

Appia Bio

appiabio.com

Cajal Neuroscience logo

Cajal Neuroscience

cajalneuro.com

Califia Bio - Quick Facts

Who are Califia Bio's competitors?

Companies similar to Califia Bio include BioHealthonomics, Santa Ana Bio, KeifeRx and Selonterra.

When was Califia Bio founded?

Califia Bio was founded in 2008.

Where is Califia Bio's headquarters located?

Califia Bio's headquarters is located in San Diego, CA, US.

When was Califia Bio's last funding round?

Califia Bio's most recent funding round was for $1.2M (USD) in March 2023.

How much has Califia Bio raised to-date?

As of Mar 17, 2023, Califia Bio has raised a total of $1.2M (USD).

How many employees does Califia Bio have?

Califia Bio has 2 employees as of Feb 5, 2024.

Califia Bio - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Main Product
  • Biotech
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified